High strength extrafine pMDI beclometasone/formoterol (200/6 μg) is effective in asthma patients not adequately controlled on medium-high dose of inhaled corticosteroids
Crossref DOI link: https://doi.org/10.1186/s12890-016-0335-9
Published Online: 2016-12-09
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Paggiaro, Pierluigi
Corradi, Massimo
Latorre, Manuela
Raptis, Helene
Muraro, Annamaria
Gessner, Christian
Siergiejko, Zenon
Scuri, Mario
Petruzzelli, Stefano
License valid from 2016-12-01